Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street

294
Comment
Favorite

Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street

The Fly2022-11-03

Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

294

Report

Comment

BitcoinMaxi
·2022-11-04
these analysts are as good as your street food vendors, dont listen to them. do your own research.
Reply
Like
Report
Simonnov
·2022-11-04
Ic
Reply
Like
Report
JY1980
·2022-11-04
Hi
Reply
1
Report
Fold Replies
- Goodmeng:
  👍
  2022-11-04
  Reply
  Report
- JY1980:
  13
  2022-11-04
  Reply
  Report
- JY1980:
  12
  2022-11-04
  Reply
  Report
View more 2 comments
Seah CL
·2022-11-04
K
Reply
1
Report
YJ Lee
·2022-11-04
Ok
Reply
3
Report
BriBri
·2022-11-04
🧐
Reply
1
Report
ML808
·2022-11-04
Ok
Reply
2
Report
g1
·2022-11-04
like
Reply
Like
Report
Hahahax
·2022-11-04
Ok
Reply
4
Report
ericbqlee
·2022-11-04
🙂
Reply
2
Report
Patjaslyn
·2022-11-04
Ok
Reply
2
Report
phantom74
·2022-11-04
like
Reply
4
Report
EAvenue
·2022-11-03
Ok
Reply
4
Report
Fold Replies
- RK888:
  👍
  2022-11-04
  Reply
  Report
- Xtraordinary:
  Hehehehe
  2022-11-04
  Reply
  Report
- k1wong:
  .
  2022-11-04
  Reply
  Report
View more 1 comments

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1170157193?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-11-03 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170157193","market":"us","top_or_hot":-1,"title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","media":"The Fly","content":"<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Source Link</a>\n\n</div>\n","source":"lsy1649979459173","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://thefly.com/news.php?onthefly=on&h=6","article_id":"1170157193","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","pubTimestamp":1667487883,"sourceInfo":{"source_id":"lsy1649979459173","name":"The Fly"},"weMediaInfo":null,"summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","collect":0,"end_time":0,"defaultTopTitle":"thefly.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4532":"文艺复兴科技持仓","BK4097":"系统软件","BK4505":"高瓴资本持仓","LU1861558580.USD":"日兴方舟颠覆性创新基金B","PATH":"UiPath","BK4524":"宅经济概念","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4548":"巴美列捷福持仓","BK4507":"流媒体概念","ROKU":"Roku Inc"},"translate_title":"Roku、菲斯克、UiPath降级：华尔街的顶级电话","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PATH":0.9,"ROKU":0.9},"content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9984169707,"gmtCreate":1667569153609,"gmtModify":1676537938837,"author":{"id":"3575705860283755","authorId":"3575705860283755","name":"BitcoinMaxi","avatar":"https://community-static.tradeup.com/news/e4a0d3f31ab627d7ead179da6e16f516","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1},"htmlText":"these analysts are as good as your&nbsp;street food vendors, dont listen to them. do your own research.","listText":"these analysts are as good as your&nbsp;street food vendors, dont listen to them. do your own research.","text":"these analysts are as good as your street food vendors, dont listen to them. do your own research.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984169707","repostId":1170157193,"repostType":2,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984957810,"gmtCreate":1667523685530,"gmtModify":1676537931011,"author":{"id":"4097750438225520","authorId":"4097750438225520","name":"Simonnov","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ic","listText":"Ic","text":"Ic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984957810","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984995200,"gmtCreate":1667517551900,"gmtModify":1676537929264,"author":{"id":"3582667225966897","authorId":"3582667225966897","name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":15,"repostSize":0,"link":"https://ttm.financial/post/9984995200","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104647896,"gmtCreate":1667518585373,"gmtModify":1667518598286,"authorId":3575588910593021,"author":{"id":3575588910593021,"authorId":3575588910593021,"name":"Goodmeng","avatar":"https://static.tigerbbs.com/96dc060537e6112d51026eaa7dd4db92","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984995200,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍<span class=\"Apple-converted-space\"> </span></span>","text":"<span class=\"s1\">👍<span class=\"Apple-converted-space\"> </span></span>","html":"<span class=\"s1\">👍<span class=\"Apple-converted-space\"> </span></span>"},{"id":104647555,"gmtCreate":1667517651661,"gmtModify":1667517667282,"authorId":3582667225966897,"author":{"id":3582667225966897,"authorId":3582667225966897,"name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.86%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984995200,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">13</span>","text":"<span class=\"s1\">13</span>","html":"<span class=\"s1\">13</span>"},{"id":104647548,"gmtCreate":1667517642735,"gmtModify":1667517658222,"authorId":3582667225966897,"author":{"id":3582667225966897,"authorId":3582667225966897,"name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.86%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984995200,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">12</span>","text":"<span class=\"s1\">12</span>","html":"<span class=\"s1\">12</span>"},{"id":104647547,"gmtCreate":1667517636000,"gmtModify":1667517651171,"authorId":3582667225966897,"author":{"id":3582667225966897,"authorId":3582667225966897,"name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.86%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984995200,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">11</span>","text":"<span class=\"s1\">11</span>","html":"<span class=\"s1\">11</span>"},{"id":104647541,"gmtCreate":1667517628966,"gmtModify":1667517644145,"authorId":3582667225966897,"author":{"id":3582667225966897,"authorId":3582667225966897,"name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.86%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984995200,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">10</span>","text":"<span class=\"s1\">10</span>","html":"<span class=\"s1\">10</span>"}],"langContent":"EN"},{"id":9984990299,"gmtCreate":1667516851012,"gmtModify":1676537929051,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984990299","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984905526,"gmtCreate":1667516465165,"gmtModify":1676537928939,"author":{"id":"4108816210230400","authorId":"4108816210230400","name":"YJ Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984905526","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984906329,"gmtCreate":1667516287861,"gmtModify":1676537928867,"author":{"id":"3581814892991688","authorId":"3581814892991688","name":"BriBri","avatar":"https://static.tigerbbs.com/a491a55c22a61b336ee95f092d522622","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"🧐","listText":"🧐","text":"🧐","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984906329","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984074809,"gmtCreate":1667515438901,"gmtModify":1676537928681,"author":{"id":"3582359360248748","authorId":"3582359360248748","name":"ML808","avatar":"https://static.tigerbbs.com/f601c68849ffbac8b7679f40f1471368","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":4,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984074809","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984078574,"gmtCreate":1667515042498,"gmtModify":1676537928573,"author":{"id":"3571438417072754","authorId":"3571438417072754","name":"g1","avatar":"https://static.itradeup.com/news/d4607e17b306e18d752d06a62d6e2db8","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984078574","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984073493,"gmtCreate":1667514709113,"gmtModify":1676537928514,"author":{"id":"4125790872105372","authorId":"4125790872105372","name":"Hahahax","avatar":"https://community-static.tradeup.com/news/e62f29147db3d658683ea37976a51736","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984073493","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984070616,"gmtCreate":1667514340336,"gmtModify":1676537928449,"author":{"id":"4101424154342900","authorId":"4101424154342900","name":"ericbqlee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"🙂","listText":"🙂","text":"🙂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984070616","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984047022,"gmtCreate":1667514177566,"gmtModify":1676537928407,"author":{"id":"3560462004935767","authorId":"3560462004935767","name":"Patjaslyn","avatar":"https://static.tigerbbs.com/d24c3405176265c91b8a1c92e36ca1e3","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984047022","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984049522,"gmtCreate":1667513096966,"gmtModify":1676537928153,"author":{"id":"3570342809089528","authorId":"3570342809089528","name":"phantom74","avatar":"https://static.tigerbbs.com/c87ef2af41b8696be86cceafb5b5723d","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984049522","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9984080714,"gmtCreate":1667488677738,"gmtModify":1676537926654,"author":{"id":"3584939916187250","authorId":"3584939916187250","name":"EAvenue","avatar":"https://static.tigerbbs.com/e3beb412a0aa565cfaac4f68f1721fd6","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/9984080714","repostId":1170157193,"repostType":4,"repost":{"id":"1170157193","pubTimestamp":1667487883,"share":"https://www.laohu8.com/m/news/1170157193?lang=&edition=full","pubTime":"2022-11-03 23:04","market":"us","language":"en","title":"Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1170157193","media":"The Fly","summary":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a ","content":"<html><head></head><body><p><b>Top 5 Upgrades:</b></p><ul><li>Citi analyst Jonmichael Shekian upgraded <a href=\"https://laohu8.com/S/FRPT\">Freshpet</a> (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.</li><li>Piper Sandler analyst David Amsellem upgraded <a href=\"https://laohu8.com/S/ALKS\">Alkermes </a> to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.</li><li>Baird analyst Joel Beatty upgraded <a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company&#39;s non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don&#39;t appear to pick up until mid-2023 and beyond.</li><li>William Blair analyst Ryan Sundby last night upgraded <a href=\"https://laohu8.com/S/LIND\">Lindblad Expeditions</a> (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management&#39;s internal expectations, Sundby tells investors in a research note.</li><li>UBS analyst Felix Liu upgraded <a href=\"https://laohu8.com/S/TAL\">TAL Education</a> (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China&#39;s &#34;Double Reduction&#34; regulation.</li></ul><p><b>Top 5 Downgrades:</b></p><ul><li>Rosenblatt analyst Barton Crockett downgraded <a href=\"https://laohu8.com/S/ROKU\">Roku </a> to Neutral from Buy with a price target of $51, down from $100, after the company&#39;s &#34;grim&#34; guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.</li><li>Canaccord analyst Maria Ripps downgraded <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company&#39;s guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.</li><li>JPMorgan analyst Harlan Sur double downgraded <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal <a href=\"https://laohu8.com/S/QTWO\">Q2</a> results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company&#39;s sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.</li><li><a href=\"https://laohu8.com/S/OPY\">Oppenheimer</a> analyst Brian Schwartz downgraded <a href=\"https://laohu8.com/S/PATH\">UiPath</a> (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath&#39;s business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.</li><li>RBC Capital analyst Joseph Spak downgraded <a href=\"https://laohu8.com/S/FSR\">Fisker </a> to Sector Perform from Outperform with a price target of $8, down from $13, after the company&#39;s Q3 earnings miss.</li></ul><p><b>Top 5 Initiations:</b></p><ul><li><a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> analyst Aaron Rakers initiated coverage of <a href=\"https://laohu8.com/S/KEYS\">Keysight</a> Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today&#39;s 20% contribution, Rakers tells investors in a research note.</li><li>Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.</li><li>Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company&#39;s self-reinforcing ecosystem with strong network effects.</li><li><a href=\"https://laohu8.com/S/COF\">Capital One</a> analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.</li><li>Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.</li></ul></body></html>","source":"lsy1649979459173","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku, Fisker, UiPath Downgraded: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku, Fisker, UiPath Downgraded: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/news.php?onthefly=on&h=6><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address ...</p>\n\n<a href=\"https://thefly.com/news.php?onthefly=on&h=6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4524":"宅经济概念","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","PATH":"UiPath","BK4507":"流媒体概念","BK4097":"系统软件","ROKU":"Roku Inc","BK4505":"高瓴资本持仓","BK4539":"次新股","LU1861558580.USD":"日兴方舟颠覆性创新基金B"},"source_url":"https://thefly.com/news.php?onthefly=on&h=6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170157193","content_text":"Top 5 Upgrades:Citi analyst Jonmichael Shekian upgraded Freshpet (FRPT) to Neutral from Sell with a price target of $66, up from $32, post third quarter results. With Freshpet working to address manufacturing and supply chain issues, the involvement of activist investor Jana Partners is a positive, even as questions remain over the likelihood of a sale of the company, Shekian tells investors in a research note.Piper Sandler analyst David Amsellem upgraded Alkermes  to Overweight from Neutral with a price target of $30, up from $26, after management announced that it is planning to separate its oncology segment in part as a means of maximizing the profitability of what will eventually be a pure-play neuropsychiatry company.Baird analyst Joel Beatty upgraded Ultragenyx Pharmaceutical (RARE) to Outperform from Neutral with a price target of $50, down from $63. The analyst believes the stock price is now attributing a value to the company's non-commercial pipeline of less than $800M, which provides an attractive entry point, even though the clinical data catalysts don't appear to pick up until mid-2023 and beyond.William Blair analyst Ryan Sundby last night upgraded Lindblad Expeditions (LIND) to Outperform from Market Perform without a price target. While Lindblad had expected to return to profitability during Q3, the results clearly exceeded even management's internal expectations, Sundby tells investors in a research note.UBS analyst Felix Liu upgraded TAL Education (TAL) to Buy from Neutral with a price target of $6.50, up from $4.94, after the company reported what he notes was its first quarterly profit since China's \"Double Reduction\" regulation.Top 5 Downgrades:Rosenblatt analyst Barton Crockett downgraded Roku  to Neutral from Buy with a price target of $51, down from $100, after the company's \"grim\" guidance for Q4. Guggenheim analyst Michael Morris also downgraded Roku to Neutral from Buy.Canaccord analyst Maria Ripps downgraded Zillow Group (ZG) to Hold from Buy with a price target of $34, down from $48, post third quarter results. The company's guidance for Q4 came in meaningfully below expectations, reflecting a worsening real estate environment with rising, volatile mortgage rates impacting affordability and constricting shopping behavior, Ripps tells investors in a research note.JPMorgan analyst Harlan Sur double downgraded Qorvo (QRVO) to Underweight from Overweight with a price target of $90, down from $125, following fiscal Q2 results. Intensifying global macro headwinds, combined with sizeable excess inventories at Qorvo and customers, pose increasing challenges to the company's sales growth and profitability recovery in the near- to mid-term, Sur tells investors in a research note.Oppenheimer analyst Brian Schwartz downgraded UiPath (PATH) to Perform from Outperform without a price target. The analyst believes the macro environment, competitive and internal pressures on improving UiPath's business, and slow adoption as an enterprise-wide platform will continue to weigh on near-term fundamentals and sentiment.RBC Capital analyst Joseph Spak downgraded Fisker  to Sector Perform from Outperform with a price target of $8, down from $13, after the company's Q3 earnings miss.Top 5 Initiations:Wells Fargo analyst Aaron Rakers initiated coverage of Keysight Technologies (KEYS) with an Overweight rating and $200 price target. The company can continue to expand margins by driving its software mix above today's 20% contribution, Rakers tells investors in a research note.Roth Capital analyst Brian Wright initiated coverage of Blue Star Foods (BSFC) with a Buy rating and $3 price target. The analyst believes there are important near-, mid- and long-term drivers that should benefit Blue Start Foods shares going forward.Citi analyst Nelson Cheung initiated coverage of PropertyGuru (PGRU) with a Buy rating and $7 price target. The analyst likes the company's self-reinforcing ecosystem with strong network effects.Capital One analyst Timothy Chiang initiated coverage of Akoya Biosciences (AKYA) with an Overweight rating and $19 price target.Deutsche Bank analyst Matthias Pfeifenberger reinstated coverage of HeidelbergCement (HDELY) with a Hold rating and EUR 50 price target. The analyst says another profit warning seems priced into the shares.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104646713,"gmtCreate":1667514133539,"gmtModify":1667514146720,"authorId":3584063721837527,"author":{"id":3584063721837527,"authorId":3584063721837527,"name":"RK888","avatar":"https://static.tigerbbs.com/c94493ec39af6df82d06fcfa8afb3483","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984080714,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍</span>","text":"<span class=\"s1\">👍</span>","html":"<span class=\"s1\">👍</span>"},{"id":104646710,"gmtCreate":1667514129360,"gmtModify":1667514142268,"authorId":3579992023257087,"author":{"id":3579992023257087,"authorId":3579992023257087,"name":"Xtraordinary","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.24","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984080714,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Hehehehe</span>","text":"<span class=\"s1\">Hehehehe</span>","html":"<span class=\"s1\">Hehehehe</span>"},{"id":104646149,"gmtCreate":1667510967919,"gmtModify":1667510980888,"authorId":3574996050082067,"author":{"id":3574996050082067,"authorId":3574996050082067,"name":"k1wong","avatar":"https://static.tigerbbs.com/f9f3b0884767b721ac5720e7a17adeba","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.21%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984080714,"type":1,"supId":0,"prevId":0,"content":".","text":".","html":"."},{"id":104646118,"gmtCreate":1667510706149,"gmtModify":1667510719625,"authorId":4090418903913760,"author":{"id":4090418903913760,"authorId":4090418903913760,"name":"FatKid","avatar":"https://community-static.tradeup.com/news/f6692ab34697d0d2f7947fa3f34c6421","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9984080714,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">K</span>","text":"<span class=\"s1\">K</span>","html":"<span class=\"s1\">K</span>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":294,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}